Evidence map›Paper›PMID 28610579›Full record

ArticleMalaria journal2017

Reported community-level indoor residual spray coverage from two-stage cluster surveys in sub-Saharan Africa.

David A Larsen, Lauren Borrill, Ryan Patel, Lauren Fregosi

Abstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David A LarsenDepartment of Public Health, Food Studies and Nutrition, Syracuse University, Syracuse, NY, USA. dalarsen@syr.edu.ORCID 0000-0002-1876-6536
Lauren BorrillDepartment of Public Health, Food Studies and Nutrition, Syracuse University, Syracuse, NY, USA.
Ryan PatelDepartment of Public Health, Food Studies and Nutrition, Syracuse University, Syracuse, NY, USA.
Lauren FregosiDepartment of Public Health, Food Studies and Nutrition, Syracuse University, Syracuse, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria is an important cause of morbidity and mortality in malaria-endemic areas. Indoor residual spray is an effective intervention to control malaria, but high community-level coverage is needed to maximize its impact. METHODS AND

resultsUsing thirty-four two-stage cluster surveys (e.g., demographic and health surveys) and lot quality assurance sampling, indoor residual spray was estimated at the community level (i.e. enumeration-area) across sub-Saharan Africa since 2010. For communities receiving indoor residual spray a logistic regression predicted whether community-level coverage exceeded 50% or not. Household-level coverage was equitable both in terms of wealth and urban/rural, with poorer and rural houses more likely to be sprayed than richer and urban houses. Coverage of indoor residual spray at the community level is poor across the continent, with 54% of communities receiving the intervention not reaching 50% coverage. Having >50% coverage at the community-level was not associated with increasing the number of houses sprayed in the country.

conclusionsImplementation and monitoring of indoor residual coverage at small geographical scales need to improve greatly to receive maximum benefit of the intervention.

Indexed as

Mosquito VectorsAdolescentAdultAerosolsAfrica South of the SaharaAnimalsChild, PreschoolCluster AnalysisFemaleHousingHumansIncomeInfantInsecticide-Treated BednetsInsect RepellentsLogistic ModelsAerosolsInsect RepellentsCommunity-level coverageImplementationIndoor residual sprayVector control

Identifiers

PMID28610579
PMCPMC5470197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.